OR WAIT null SECS
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
June 2, 2015.
Following the "morning after" pill's release from prescription requirement in Germany on March 14 this year, sales increased in April by more than 10 per cent to 55.000 packs, according to data from INSIGHT Health. The increase also represents a 25 percent gain on the strongest sales month in 2014.
Almost 100 percent of emergency contraceptives in Germany are sold by ellaOne and HRA-Pharma's PiDaNa. While the monthly sales quantity of ellaOne more than doubled during the last six months, PiDaNa shows a decrease of more than a third in its monthly sales quantity. This however is because PiDaNa's Levonorgestrel was not released from prescription requirement until after ellaOnes’ Ulipristal, reports INSIGHT.